Senior insider sale
Chief Scientific Officer at CARTESIAN THERAPEUTICS, INC. — senior position signals high conviction
$141.7K
19.45K shares
What this filing means
JEWELL CHRISTOPHER M plans to sell 19.45K shares of CARTESIAN THERAPEUTICS, INC. valued at approximately $141.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/9/2026ACC: 0001950047-26-000312
Officer· Chief Scientific Officer
Since Nov 2023
19.45K
Shares to sell
$141.7K
Approx. market value
1.51K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Services Rendered
1/2/2026
1.51KTotal acquired1.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Restricted stock vesting under a registered plan Services Rendered | 1.51K | — |
| Total | 1.51K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
17.93K
Market value
$129.6K
11/19/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.51K
Market value
$12.1K
1/9/2026
Total
Units
19.45K
Value
$141.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/19/2025 | 17.93K | $129.6K | — | Completed |
| Planned — Approximate Date | ||||
1/9/2026 | 1.51K | $12.1K | NASDAQ | Planned |
| Total | 19.45K | $141.7K | ||